This inventor holds 1 USPTO granted patent. Top assignee: Institut Pasteur. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Rasmus Lundquist: Innovator in Antibody Research
Introduction
Rasmus Lundquist is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant human antibodies. His work focuses on innovative solutions for treating diseases, including malaria.
Latest Patents
Rasmus Lundquist holds one patent related to a recombinant human antibody that is specific for the MSP-3 antigen. This invention encompasses not only the antibody sequence but also the nucleic acid encoding such antibodies. The potential applications of this invention are particularly relevant in the treatment or prophylaxis of malaria.
Career Highlights
Lundquist is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work at this renowned institution underscores his commitment to advancing medical science and improving public health outcomes.
Collaborations
Some of his notable coworkers include Morten Steen Hanefeld Dziegiel and Leif Kofoed Nielsen. Their collaborative efforts contribute to the innovative research environment at Institut Pasteur.
Conclusion
Rasmus Lundquist's contributions to antibody research exemplify the impact of innovation in biotechnology. His work holds promise for significant advancements in the treatment of malaria and other diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile